MICHAEL HOLLIDAY to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications MICHAEL HOLLIDAY has written about Randomized Controlled Trials as Topic.
Connection Strength
0.149
-
Emerging evidence for glucagon-like peptide-1 agonists in slowing chronic kidney disease progression. Curr Opin Nephrol Hypertens. 2024 05 01; 33(3):331-336.
Score: 0.149
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.